Spotting A Winner: Oragenics Inc (AMEX: OGEN) Retreats -2.02 And It Still Have Room To Run

Oragenics Inc (AMEX:OGEN) currently has a daily average trading volume of 4.89M but it saw 211258 shares traded in last market. With a market cap of 3.76M USD, the company’s current market price of $0.17 came falling about -2.02 while comparing to the previous closing price of $0.18. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.43 and as low as $0.16. In the recent trading on the day, stock has struck highest price mark of $0.17 while lowest mark touched by it was $0.18.

Taking a look at 20-day trading activity of Oragenics Inc (OGEN) gives us an average price of $0.2062, while its current price level is -94.90% below from 52-week high level whereas it is 8.23% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2499 while that of 200 days or SMA-200 reads an average of $0.5037. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.60% during that period while stretching the period over a month that increases to 9.16%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 30.88 which implies that the stock is in neutral territory.

Over the week, OGEN’s stock price is moving -1.13% down while it is -31.26% when we observe its performance for the past one month. Year-to-date it is -52.61% down and over the past year, the stock is showing a downside performance of -83.80%.

The company is expected to be releasing its next quarterly report on 2023-May-11, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.

Currently, Oragenics Inc’s total number of outstanding shares is 21.48M with 13.28% of that held by the insiders while 1.14% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -714.95%. Stock’s beta reads 1.17. Its return on asset (ROA) is -328.26% on average.